ALDH1A1 and breast carcinoma: In breast cancer, elevated levels of IL-33 have been correlated with increased proliferation, immunosuppression, and upregulation of CSC markers such as CD44 and ALDH1, primarily through activation of the Wnt/β-catenin signaling pathway [217].